Identification of an interleukin 17F/17A heterodimer in activated human CD4+T cells

被引:252
作者
Wright, Jill F.
Guo, Yongjing
Quazi, Amira
Luxenberg, Deborah P.
Bennett, Frann
Ross, John F.
Qiu, Yongchang
Whitters, Matthew J.
Tomkinson, Kathleen N.
Dunussi-Joannopoulos, Kyri
Carreno, Beatriz M.
Collins, Mary
Wolfman, Neil M.
机构
[1] Wyeth Res, Dept Inflammat, Cambridge, MA 02140 USA
[2] Wyeth Res, Dept Biol Technol, Cambridge, MA 02140 USA
关键词
D O I
10.1074/jbc.M700499200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
IL-17F and IL-17A are members of the IL-17 pro-inflammatory cytokine family. IL-17A has been implicated in the pathogenesis of autoimmune diseases. IL-17F is a disulfide-linked dimer that contains a cysteine-knot motif. We hypothesized that IL-17F and IL-17A could form a heterodimer due to their sequence homology and overlapping pattern of expression. We evaluated the structure of recombinant IL-17F and IL-17A proteins, as well as that of natural IL-17F and IL-17A derived from activated human CD4(+) T cells, by enzyme-linked immunosorbent assay, immunoprecipitation followed by Western blotting, and mass spectrometry. We find that both IL-17F and IL-17A can form both homodimeric and heterodimeric proteins when expressed in a recombinant system, and that all forms of the recombinant proteins have in vitro functional activity. Furthermore, we find that in addition to the homodimers of IL-17F and IL-17A, activated human CD4+ T cells also produce the IL-17F/ IL-17A heterodimer. These data suggest that the IL-17F/ IL-17A heterodimer may contribute to the T cell-mediated immune responses.
引用
收藏
页码:13447 / 13455
页数:9
相关论文
共 36 条
[1]   Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 [J].
Aggarwal, S ;
Ghilardi, N ;
Xie, MH ;
de Sauvage, FJ ;
Gurney, AL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) :1910-1914
[2]   Serum levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17 and IL-18 in patients with active psoriasis and correlation with disease severity [J].
Arican, O ;
Aral, M ;
Sasmaz, S ;
Ciragil, P .
MEDIATORS OF INFLAMMATION, 2005, (05) :273-279
[3]   Novel pro-inflammatory interleukins: potential therapeutic targets in rheumatoid arthritis [J].
Bessis, N ;
Boissier, MC .
JOINT BONE SPINE, 2001, 68 (06) :477-481
[4]   Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238
[5]   IL-17 cytokine/receptor families: emerging targets for the modulation of inflammatory responses [J].
Dumont, FJ .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (03) :287-303
[6]   T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines [J].
Fossiez, F ;
Djossou, O ;
Chomarat, P ;
FloresRomo, L ;
AitYahia, S ;
Maat, C ;
Pin, JJ ;
Garrone, P ;
Garcia, E ;
Saeland, S ;
Blanchard, D ;
Gaillard, C ;
DasMahapatra, B ;
Rouvier, E ;
Golstein, P ;
Banchereau, J ;
Lebecque, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (06) :2593-2603
[7]   Increased expression of interleukin 17 in inflammatory bowel disease [J].
Fujino, S ;
Andoh, A ;
Bamba, S ;
Ogawa, A ;
Hata, K ;
Araki, Y ;
Bamba, T ;
Fujiyama, Y .
GUT, 2003, 52 (01) :65-70
[8]   Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages [J].
Harrington, LE ;
Hatton, RD ;
Mangan, PR ;
Turner, H ;
Murphy, TL ;
Murphy, KM ;
Weaver, CT .
NATURE IMMUNOLOGY, 2005, 6 (11) :1123-1132
[9]   New IL-17 family members promote Th1 or Th2 responses in the lung: In vivo function of the novel cytokine IL-25 [J].
Hurst, SD ;
Muchamuel, T ;
Gorman, DM ;
Gilbert, JM ;
Clifford, T ;
Kwan, S ;
Menon, S ;
Seymour, B ;
Jackson, C ;
Kung, TT ;
Brieland, JK ;
Zurawski, SM ;
Chapman, RW ;
Zurawski, G ;
Coffman, RL .
JOURNAL OF IMMUNOLOGY, 2002, 169 (01) :443-453
[10]   IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding [J].
Hymowitz, SG ;
Filvaroff, EH ;
Yin, JP ;
Lee, J ;
Cai, LP ;
Risser, P ;
Maruoka, M ;
Mao, WG ;
Foster, J ;
Kelley, RF ;
Pan, GH ;
Gurney, AL ;
de Vos, AM ;
Starovasnik, MA .
EMBO JOURNAL, 2001, 20 (19) :5332-5341